Arcus Prices 14.3 Million-Share Offering at $17.50 Each
Arcus Biosciences expects to raise $250 million in gross proceeds from the follow-on share sale, before underwriting discounts and expenses. Shares fell premarket.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.